Prognostic factors in potentially resectable stage III non-small cell lung cancer receiving neoadjuvant treatment—a narrative review

Lung cancer is the leading cause of cancer-related death in worldwide. The most important treatment for patients with stage I and II non-small cell lung cancer (NSCLC) is surgery. Resected stage II and III NSCLC patients should be offered adjuvant chemotherapy and in patients with resected stage IB...

Full description

Saved in:
Bibliographic Details
Published in:Transl Lung Cancer Res
Main Authors: Calvo, Virginia, Aliaga, Carlos, Carracedo, Carlos, Provencio, Mariano
Format: Artigo
Language:Inglês
Published: AME Publishing Company 2021
Subjects:
Review Articles on Multimodal Management of Locally Advanced N2 Non-small Cell Lung Cancer
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7867763/
https://ncbi.nlm.nih.gov/pubmed/33569338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-515
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items